Ditropan and Dapsone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ditropan (oxybutynin chloride) and Dapsone (dapsone). Common drug interactions include headache among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Ditropan and Dapsone. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Dapsone?

Dapsone has active ingredients of dapsone. It is often used in dermatitis herpetiformis. eHealthMe is studying from 11,732 Dapsone users. Check the latest studies of Dapsone.



On Jul, 20, 2026

39 people who take Ditropan and Dapsone together, and have interactions are studied.

Ditropan and Dapsone drug interactions.

What are the common drug interactions of Ditropan and Dapsone, by gender? *:

female:

  1. Headache (pain in head)
  2. Asterixis (flapping tremor, or liver flap)
  3. Cervical vertebral fracture
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Fracture
  6. Myelopathy (any neurologic deficit related to the spinal cord)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Rib fracture
  9. Factor viii inhibition (suppression of factor viii)
  10. Arthralgia (joint pain)

male:

  1. Arthralgia (joint pain)
  2. Oedema peripheral (superficial swelling)
  3. Hyperkeratosis (thickening of the outer layer of the skin)
  4. Injury
  5. Joint instability (a condition in which the joints aren't sufficiently supported)
  6. Joint range of motion decreased (disease of joint movement)
  7. Joint stiffness
  8. Mobility decreased (ability to move is reduced)
  9. Muscular weakness (muscle weakness)
  10. Myalgia (muscle pain)

What are the common drug interactions of Ditropan and Dapsone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Depression
  2. Fall
  3. Femur fracture
  4. Forearm fracture (fracture in between wrist to elbow)
  5. Gastric ulcer (stomach ulcer)
  6. Gastritis (inflammation of stomach)
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Lower limb fracture
  10. Oesophageal spasm (contraction of oesophagus)

40-49:

  1. Carcinoma (cancer)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting

50-59:

  1. Blood glucose increased
  2. Blood thyroid stimulating hormone decreased
  3. Chills (felling of cold)
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Cystitis (inflammation of the wall of the bladder)
  6. Cystitis haemorrhagic (blood in the urine and painful voiding)
  7. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  8. Dehydration (dryness resulting from the removal of water)
  9. Diarrhoea
  10. Dizziness

60+:

  1. Arthralgia (joint pain)
  2. Oedema peripheral (superficial swelling)
  3. Hyperkeratosis (thickening of the outer layer of the skin)
  4. Injury
  5. Joint instability (a condition in which the joints aren't sufficiently supported)
  6. Joint range of motion decreased (disease of joint movement)
  7. Joint stiffness
  8. Mobility decreased (ability to move is reduced)
  9. Muscular weakness (muscle weakness)
  10. Myalgia (muscle pain)

What are the existing conditions these people have? *

  1. Depression: 16 people, 41.03%
  2. Anaemia (lack of blood): 12 people, 30.77%
  3. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 9 people, 23.08%
  4. Polymyalgia Rheumatica (pain in many muscles): 9 people, 23.08%
  5. High Blood Pressure: 8 people, 20.51%
  6. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 7 people, 17.95%
  7. Vasculitis (inflammation of a blood vessel or blood vessels): 5 people, 12.82%
  8. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 5 people, 12.82%
  9. Allergic Rhinitis: 5 people, 12.82%
  10. Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 5 people, 12.82%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and Dapsone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ditropan and Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dapsone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ditropan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dapsone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride and dapsone (the active ingredients of Ditropan and Dapsone, respectively), and Ditropan and Dapsone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: